Kenneth D Coblentz

Title: The Innovations of Kenneth D Coblentz

Introduction

Kenneth D Coblentz is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of methods for detecting target analytes in biological samples. With a total of 2 patents, his work has advanced the capabilities of diagnostic technologies.

Latest Patents

Coblentz's latest patents include innovative methods for detecting targets on an array. This invention focuses on detecting target analytes in biological samples using composite microsphere arrays that feature first and second assay locations. The preferred target analytes include nucleic acids, specifically those with one or more single nucleotide polymorphisms (SNPs). Another significant patent involves array compositions and methods of making the same. This invention relates to sensor compositions that comprise a composite array of individual arrays, allowing for the simultaneous processing of multiple samples. Additionally, it provides methods for creating and utilizing these composite arrays, along with a hybridization chamber designed for use with them.

Career Highlights

Coblentz is currently associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has positioned him at the forefront of innovative research and development in biotechnology.

Collaborations

Throughout his career, Coblentz has collaborated with esteemed colleagues such as Todd Alan Dickinson and Edward Scott Carlson. These collaborations have further enriched his contributions to the field.

Conclusion

Kenneth D Coblentz's innovative work in biotechnology, particularly in the detection of target analytes, showcases his significant impact on the industry. His patents reflect a commitment to advancing diagnostic technologies, making him a key figure in his field.